Evidence map›Paper›PMID 21368169›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Predicting clonal self-renewal and extinction of hematopoietic stem cells.

Hans B Sieburg, Betsy D Rezner, Christa E Muller-Sieburg

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Clinical Data for Parametrization ofFrontiers in bioengineering and biotechnology · 2022
    Pooled it
  2. Article
  3. Smoking drives an epigenetic memory of aberrant hematopoiesis.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Mapping Hematopoietic Fate after Transplantation.Stem cell reviews and reports · 2025
    Review
  5. Article
  6. Other Immunomodulatory Treatment for Cytokine Storm Syndromes.Advances in experimental medicine and biology · 2024
    Review
  7. A computational model for the cancer field effect.Frontiers in artificial intelligence · 2023
    Article
  8. Hematopoietic Stem Cells and Regeneration.Cold Spring Harbor perspectives in biology · 2022
    Review
  9. DNA damage and repair in the hematopoietic system.Acta biochimica et biophysica Sinica · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Revisiting the tumorigenesis timeline with a data-driven generative model.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hans B SieburgStem Cells and Regenerative Biology Program, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. hsieburg@sanfordburnham.org
Betsy D Rezner
Christa E Muller-Sieburg
Dana-Farber Cancer Institute · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

STROMAL CELL MOLECULES REGULATE STEM CELL PROLIFERATIONR01DK048015 · NIDDK · SIDNEY KIMMEL CANCER CENTER · PI SIEBURG, HANS B · 1996 to 2012
$4.5M
CLONAL ANALYSIS OF AGED HEMATOPOIETIC STEM CELLSR01AG023197 · NIA · SIDNEY KIMMEL CANCER CENTER · PI MULLER-SIEBURG, CHRISTA E. · 2004 to 2008
$1.8M
Howard Hughes Medical InstituteNIA NIH HHS AG023197NIA NIH HHS R01 AG023197NIDDK NIH HHS DK48018NIDDK NIH HHS R01 DK048015
6 · The paper itself

Abstract

A single hematopoietic stem cell (HSC) can generate a clone, consisting of daughter HSCs and differentiated progeny, which can sustain the hematopoietic system of multiple hosts for a long time. At the same time, this massive expansion potential must be restrained to prevent abnormal, leukemic proliferation. We used an interdisciplinary approach, combining transplantation assays with mathematical and computational methods, to systematically analyze the proliferative potential of individual HSCs. We show that all HSC clones examined have an intrinsically limited life span. Daughter HSCs within a clone behaved synchronously in transplantation assays and eventually exhausted at the same time. These results indicate that each HSC is programmed to have a finite life span. This program and the memory of the life span of the mother HSC are inherited by all daughter HSCs. In contrast, there was extensive heterogeneity in life spans between individual HSC clones, ranging from 10 to almost 60 mo. We used model-based machine learning to develop a mathematical model that efficiently predicts the life spans of individual HSC clones on the basis of a few initial measurements of donor type cells in blood. Computer simulations predict that the probability of self-renewal decays with a logistic kinetic over the life span of a normal HSC clone. Other decay functions lead to either graft failure or leukemic proliferation. We propose that dynamical fate probabilities are a crucial condition that leads to self-limiting clonal proliferation.

Indexed as

Cellular SenescenceAnimalsCell ProliferationClone CellsComputer SimulationHematopoietic Stem CellsKineticsMiceModels, ImmunologicalTime Factors

Identifiers

PMID21368169
PMCPMC3060234
OpenAlexW2069565851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.